Investigation of Long Non-Coding RNAs H19 rs3741219, MEG3 rs7158663, POLR2E rs3787016, and ANRIL rs10757274 with Breast Cancer Susceptibility and Clinicopathological Characteristics in a Mexican Population
Authors:
- Mónica Alejandra Rosales-ReynosoMRMónica Alejandra Rosales-Reynoso
- Anilú Margarita Saucedo-SariñanaASAnilú Margarita Saucedo-Sariñana
- Clara Ibet Juárez-VázquezCJClara Ibet Juárez-Vázquez
- César de Jesús Tovar-JácomeCTCésar de Jesús Tovar-Jácome
- Rubria Alicia González-SánchezRGRubria Alicia González-Sánchez
- Karen Guadalupe Mestas-VillagranKMKaren Guadalupe Mestas-Villagran
- Gustavo Andrés Torres-SánchezGTGustavo Andrés Torres-Sánchez
- José Elías García-OrtízJGJosé Elías García-Ortíz
- Efraín Salas-GonzálezESEfraín Salas-González
- Martha Patricia Gallegos-ArreolaMartha Patricia Gallegos-Arreola
Open Access
- 4 June 2026
- journal article
- research article
- Published by MDPI AG in Non-Coding RNA
- Vol. 12 (3) , 19
Abstract
Recent evidence has highlighted the crucial role of non-coding genetic elements in regulating gene expression and has been linked to a broad range of biological functions. Notably, dysregulation of long non-coding RNAs has been strongly associated with tumorigenesis and cancer progression. Background/Objectives: This study aimed to investigate the potential association between the H19 rs3741219 T>C, MEG3 rs7158663 G>A, POLR2E rs3787016 T>C, and ANRIL rs10757274 A>G variants and Breast Cancer (BC) susceptibility, as well as their relationship with clinicopathological characteristics in Mexican patients. Methods: DNA was obtained from peripheral blood samples of 505 women (254 patients and 251 control females). Genotyping was performed by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) methodology. Associations were calculated using odds ratios (ORs), with p-values adjusted by the Bonferroni test (p < 0.012). In silico analyses were conducted to predict the functional impact of the variants associated. Results: Patients carrying the C/C genotypes in H19 rs3741219 and POLR2E rs3787016 variants showed increased susceptibility to developing BC and with clinical and pathological characteristics (age at diagnosis, TNM stage, histologic type and molecular subtype) (p < 0.001). Conclusions: The results suggest that H19 rs3741219 and POLR2E rs3787016 variants significantly influence BC risk.Keywords
Funding Information
- Instituto Mexicano del Seguro Social (R-2020-785-130)
This publication has 60 references indexed in Scilit:
- The effects of ANRIL polymorphisms on colorectal cancer, tumor stage, and tumor grade among Iranian populationMolecular Biology Reports, 2024
- A novel lnc-LAMC2-1:1 SNP promotes colon adenocarcinoma progression by targeting miR-216a-3p/HMGB3Heliyon, 2022
- ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)Annals of Oncology, 2022
- The association of lncRNA SNPs and SNPs‐environment interactions based on GWAS with HBV‐related HCC risk and progressionMolecular Genetics & Genomic Medicine, 2021
- Polymorphism of lncRNAs in breast cancer: Meta‐analysis shows no association with susceptibilityThe Journal of Gene Medicine, 2020
- H19 lncRNA: Roles in tumorigenesisBiomedicine & Pharmacotherapy, 2020
- MEG3: an Oncogenic Long Non-coding RNA in Different CancersPathology and Oncology Research, 2019
- Association of the study between LncRNA‐H19 gene polymorphisms with the risk of breast cancerJournal of Clinical Laboratory Analysis, 2018
- Genetic variants in long noncoding RNA H19 and MEG3 confer risk of type 2 diabetes in an Iranian populationGene, 2018
- Long non-coding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancerBiomedicine & Pharmacotherapy, 2017